SCHEMBL13071878

SCHEMBL13071878

NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCC/C=C\[C@@H]1C[C@@H]1C(=O)NS(=O)(=O)C1CC1)Nc1ccc(F)c(C(F)(F)F)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XIAP P98170 7/20 0.34
F2R P25116 2/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CG P48736 1/20 0.32
UBE2M P61081 1/20 0.32
DCUN1D1 Q96GG9 1/20 0.32
ACE P12821 2/20 0.32
BIRC3 Q13489 2/20 0.31
BIRC2 Q13490 2/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
RORC P51449 1/20 0.30
DPP4 P27487 1/20 0.30
F2 P00734 2/20 0.30
PRSS1 P07477 2/20 0.30
PRSS2 P07478 2/20 0.30
PRSS3 P35030 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13071524 0.89 HTR1A (0.36) ACEDPP4F2PRSS1PRSS2
SCHEMBL13072094 0.88 USP2 (0.34) F2RACEF2PRSS1PRSS2
SCHEMBL13071668 0.88 ACE (0.33) ACEF2PRSS1PRSS2PRSS3
SCHEMBL13071393 0.88 DPP4 (0.32) XIAPF2RUBE2MDCUN1D1DPP4
SCHEMBL13072090 0.88 HTT (0.38) ACEF2PRSS1PRSS2PRSS3
SCHEMBL13071526 0.87 UBE2M (0.35) XIAPF2RUBE2MDCUN1D1ACE
SCHEMBL13071425 0.86 ACE (0.38) ACEDPP4F2PRSS1PRSS2
SCHEMBL13071521 0.86 CFD (0.39) CYP2C9
SCHEMBL13072089 0.86 F2R (0.33) F2RACEDPP4
SCHEMBL12831783 0.83 F2R (0.34) XIAPF2RPIK3CDPIK3CAPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009142842-A9 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2010-11-25 WO disclosed
WO-2009142842-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-11-26 WO disclosed